BR112021016778A2 - Vacinas contra influenza multivalentes com adjuvante e usos - Google Patents
Vacinas contra influenza multivalentes com adjuvante e usosInfo
- Publication number
- BR112021016778A2 BR112021016778A2 BR112021016778A BR112021016778A BR112021016778A2 BR 112021016778 A2 BR112021016778 A2 BR 112021016778A2 BR 112021016778 A BR112021016778 A BR 112021016778A BR 112021016778 A BR112021016778 A BR 112021016778A BR 112021016778 A2 BR112021016778 A2 BR 112021016778A2
- Authority
- BR
- Brazil
- Prior art keywords
- multivalent
- antigens
- influenza
- oil
- vaccine
- Prior art date
Links
- 229960003971 influenza vaccine Drugs 0.000 title abstract 4
- 239000002671 adjuvant Substances 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 3
- 239000007764 o/w emulsion Substances 0.000 abstract 2
- 241000712461 unidentified influenza virus Species 0.000 abstract 2
- 239000000839 emulsion Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
vacinas contra influenza multivalentes com adjuvante e usos. a presente invenção está relacionada a composições de vacina compreendendo a) antígenos de pelo menos três cepas diferentes do vírus influenza, preferencialmente pelo menos quatro cepas diferentes do vírus influenza e b) um adjuvante de emulsão óleo em água, em que a quantidade do adjuvante de emulsão óleo em água é maior do que uma quantidade de um adjuvante de emulsão óleo em água em uma vacina contra influenza multivalente com adjuvante de dose padrão. além disso, a quantidade total dos antígenos nas composições de vacina pode ser maior do que uma quantidade total de antígenos em uma vacina contra influenza multivalente com adjuvante de dose padrão. em aspectos preferenciais, a presente invenção descreve adicionalmente usos dessas composições de vacina para indução segura e eficaz de respostas imunes em adultos com pelo menos 65 anos de idade.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809914P | 2019-02-25 | 2019-02-25 | |
| PCT/IB2020/000207 WO2020174288A1 (en) | 2019-02-25 | 2020-02-24 | Adjuvanted multivalent influenza vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021016778A2 true BR112021016778A2 (pt) | 2021-11-16 |
Family
ID=70680531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021016778A BR112021016778A2 (pt) | 2019-02-25 | 2020-02-24 | Vacinas contra influenza multivalentes com adjuvante e usos |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220168413A1 (pt) |
| AU (1) | AU2020228151A1 (pt) |
| BR (1) | BR112021016778A2 (pt) |
| DE (1) | DE202020005621U1 (pt) |
| MX (1) | MX2021010194A (pt) |
| WO (1) | WO2020174288A1 (pt) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2383105C (en) | 1999-09-24 | 2010-01-26 | Smithkline Beecham Biologicals S.A. | Intranasal influenza virus vaccine |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| JP2004536785A (ja) | 2001-02-23 | 2004-12-09 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 新規なワクチン |
| PT1361890E (pt) | 2001-02-23 | 2011-06-07 | Glaxosmithkline Biolog Sa | Formulações vacinais de influenza para distribuição intradérmica |
| JP2009514838A (ja) | 2005-11-04 | 2009-04-09 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | 細胞培養物において増殖されたインフルエンザウイルスから調製された非ビリオン抗原を含むアジュバントワクチン |
| SG177141A1 (en) | 2006-12-06 | 2012-01-30 | Novartis Ag | Vaccines including antigen from four strains of influenza virus |
| US20120027813A1 (en) * | 2008-02-22 | 2012-02-02 | Novartis Vaccines And Diagnostics Srl | Adjuvanted influenza vaccines for pediatric use |
-
2020
- 2020-02-24 US US17/432,986 patent/US20220168413A1/en active Pending
- 2020-02-24 AU AU2020228151A patent/AU2020228151A1/en active Pending
- 2020-02-24 BR BR112021016778A patent/BR112021016778A2/pt unknown
- 2020-02-24 DE DE202020005621.9U patent/DE202020005621U1/de active Active
- 2020-02-24 WO PCT/IB2020/000207 patent/WO2020174288A1/en active Application Filing
- 2020-02-24 MX MX2021010194A patent/MX2021010194A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021010194A (es) | 2022-01-24 |
| DE202020005621U1 (de) | 2022-01-12 |
| AU2020228151A1 (en) | 2021-10-21 |
| US20220168413A1 (en) | 2022-06-02 |
| WO2020174288A1 (en) | 2020-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Honda-Okubo et al. | Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses | |
| EA200701786A1 (ru) | Поливалентная противогриппозная иммуногенная композиция | |
| BRPI0621886A8 (pt) | composição de vacina contra influenza monovalente, kit, método para a produção de uma composição de vacina contra influenza para uma situação pandêmica ou uma situação pré-pandêmica, e, usos de um antígeno de vírus da influenza ou preparação antigênica do mesmo e de um adjuvante em emulsão óleo-em-água, de um antígeno de vírus da influenza pandêmica ou preparação antigênica do antígeno de hemaglutinina do vírus da influenza, de um vírus da influenza pandêmica ou preparação antigênica do mesmo, e de um adjuvante em emulsão óleo-em-água e de um antígeno ou preparação antigênica de uma primeira cepa de influenza | |
| HRP20140488T1 (hr) | Cjepivo protiv influence | |
| de Bree et al. | Bacillus calmette–guérin-induced Trained immunity is not Protective for experimental influenza a/anhui/1/2013 (h7n9) infection in Mice | |
| BR112017017949A2 (pt) | regimes de iniciação-reforço envolvendo administração de pelo menos um constructo de mrna | |
| BR112013005427A2 (pt) | composição imunogênica, vacina, método para tratamento ou prevenção de doença, e para preparar a composição imunogênica ou vacina, uso da vacina,e, composição farmacêutica. | |
| BR112020016454A8 (pt) | Tratamento utilizando rna que codifica citocina | |
| BR0007936A (pt) | Composto, formulação adjuvante imunológica, formulação de vacina, e, processo para estimular uma resposta imune a um antìgeno | |
| BR112018068342A2 (pt) | vacina de vírus zika vivo atenuado | |
| RU2017101091A (ru) | Композиции вакцин с двойным адъювантом, получение и применения | |
| HRP20230359T1 (hr) | Imunogeni pripravak | |
| Lefebvre et al. | Vaccine strategies to enhance immune responses in the aged | |
| BR112017028212A2 (pt) | vacinação concomitante contra dengue e febre amarela | |
| Yam et al. | Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice | |
| AR099960A1 (es) | Procedimientos y composición farmaceutica para inducir una respuesta inmunitaria | |
| BR112022004488A2 (pt) | Herpesvírus recombinante de vetores de peru que expressam antígenos de patógenos aviários e seus usos | |
| Hu et al. | A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination | |
| BR112014023283A8 (pt) | Composição imunogênica, segunda composição imunogênica, e, método para prevenção e/ou tratamento contra doença influenza | |
| BR112021016778A2 (pt) | Vacinas contra influenza multivalentes com adjuvante e usos | |
| Sengler et al. | Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases | |
| RU2021117820A (ru) | Вакцина против инфекционного бронхита | |
| UY38933A (es) | Vacuna de partículas tipo virus del chicunguña y métodos para su uso | |
| Akin et al. | Evaluation of the safety and efficacy of AdvaxTM as an adjuvant: A systematic review and meta-analysis | |
| Fisher et al. | Adjuvanted vaccines against influenza in the elderly |